Logo for Mirati Therapeutics Inc

Mirati Therapeutics Investor Relations Material

Latest events

Logo for Mirati Therapeutics Inc

Q2 2023

Mirati Therapeutics
Logo for Mirati Therapeutics

Q3 2023

6 Nov, 2023
Logo for Mirati Therapeutics

Q2 2023

8 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies

Latest reports from Mirati Therapeutics Inc

Access all reports
Mirati Therapeutics Inc. is a clinical-stage biotechnology company focused on developing targeted cancer therapies. The company specializes in the research and development of treatments aimed at addressing genetic and epigenetic drivers of cancer. Mirati’s pipeline includes precision oncology candidates designed to inhibit specific molecular targets associated with tumor growth and progression. The company is headquartered in San Diego, California, and its shares are listed on the NASDAQ.